Johnson & Johnson
JNJ
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGXā¦ read more
Healthcare
Drug Manufacturers - General
80 years
USD
85
/100
Price
per share adjusted in USD$155.17
Price-1.05%
-$1.65
1Y
Price
Market Cap
$373.350b
Large
Price/Earnings
17.3x
17.1x
3y Avg17.1x
5y AvgDividends
Ex-Dividend: May 27, 253.35%
Yield$5.20
Dividend+5.69%
Forward Dividend Growth
+5.7%
+5.8%
3y CAGR+5.9%
5y CAGRPayout
57.8%
54.7%
Payout 3y60.0%
Payout 5yYield
BenchmarkDividends
No items found.
Financials Overview
Key metrics over the past few years+71.3%
EBITDA Margin+50.2%
Net Profit Margin+15.4%
Free Cash Flow MarginRevenue
$89.331b
+0.6%
1y CAGR+3.8%
3y CAGR+3.2%
5y CAGREarnings
$21.810b
+55.1%
1y CAGR+30.3%
3y CAGR+19.2%
5y CAGREPS
$8.99
+55.3%
1y CAGR+33.8%
3y CAGR+21.9%
5y CAGRBook Value
$78.109b
$193.671b
Assets$115.562b
Liabilities$52.252b
DebtDebt to Assets
27.0%
1.5x
Debt to EBITDAFree Cash Flow
$18.574b
-6.4%
1y CAGR+2.9%
3y CAGR-1.1%
5y CAGRFinancial Reports
Earnings and other important metricsNo items found.
Press Releases
Statements and updates from the company